Cepas-Guillén Pedro, Flores-Umanzor Eduardo, Horlick Eric, Aboulhosn Jamil, Benson Lee, Freixa Xavier, Houde Christine, Rodés-Cabau Josep
Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
Nat Rev Cardiol. 2025 Jan 20. doi: 10.1038/s41569-025-01118-1.
Advances in imaging diagnostics, surgical techniques and transcatheter interventions for paediatric patients with severe congenital heart disease (CHD) have substantially reduced mortality, thereby extending the lifespan of these individuals and increasing the number of adults with complex CHD. Transcatheter interventions have emerged as an alternative to traditional open-heart surgery to mitigate congenital defects. The evolution of techniques, the introduction of new devices and the growing experience of operators have enabled the treatment of patients with progressively more complex conditions. The general cardiology community might be less aware of contemporary interventions for adult CHD, their clinical indications and associated outcomes than interventional cardiologists and congenital heart specialists. In this Review, we provide a comprehensive evaluation of the available transcatheter interventions for adult patients with CHD.
对于患有严重先天性心脏病（CHD）的儿科患者，成像诊断、手术技术和经导管介入治疗取得的进展已大幅降低了死亡率，从而延长了这些患者的寿命，并增加了患有复杂CHD的成年人数量。经导管介入治疗已成为传统心脏直视手术的替代方法，用于减轻先天性缺陷。技术的发展、新设备的引入以及操作人员经验的增加，使得越来越复杂病情的患者也能得到治疗。与介入心脏病学家和先天性心脏病专家相比，普通心脏病学界可能对成人CHD的当代介入治疗、其临床适应症及相关结果了解较少。在本综述中，我们对现有的成人CHD经导管介入治疗进行了全面评估。
